Annual EBIT
-$46.30 M
-$16.04 M-53.02%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual earnings before interest & taxes is -$46.30 million, with the most recent change of -$16.04 million (-53.02%) on December 31, 2023.
- During the last 3 years, CRMD annual EBIT has fallen by -$19.14 million (-70.46%).
- CRMD annual EBIT is now -1444.68% below its all-time high of -$3.00 million, reached on December 31, 2012.
Performance
CRMD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.77 M
+$11.38 M+80.44%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly earnings before interest & taxes is -$2.77 million, with the most recent change of +$11.38 million (+80.44%) on September 30, 2024.
- Over the past year, CRMD quarterly EBIT has increased by +$11.98 million (+81.24%).
- CRMD quarterly EBIT is now -178.83% below its all-time high of $3.51 million, reached on June 30, 2014.
Performance
CRMD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$47.51 M
+$6.96 M+12.78%
September 30, 2024
Summary
- As of February 7, 2025, CRMD TTM earnings before interest & taxes is -$47.51 million, with the most recent change of +$6.96 million (+12.78%) on September 30, 2024.
- Over the past year, CRMD TTM EBIT has dropped by -$1.21 million (-2.60%).
- CRMD TTM EBIT is now -7344.42% below its all-time high of -$638.20 thousand, reached on March 31, 2009.
Performance
CRMD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRMD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.0% | +81.2% | -2.6% |
| 3 y3 years | -70.5% | +66.3% | -57.0% |
| 5 y5 years | -72.6% | +53.0% | -84.4% |
CRMD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | at low | at high | +82.5% | -62.4% | +12.8% |
| 5 y | 5-year | -123.6% | at low | at high | +82.5% | -129.4% | +12.8% |
| alltime | all time | -1444.7% | at low | -178.8% | +83.5% | -7344.4% | +12.8% |
CorMedix EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.77 M(-80.4%) | -$47.51 M(-12.8%) |
| Jun 2024 | - | -$14.14 M(-10.8%) | -$54.47 M(+5.6%) |
| Mar 2024 | - | -$15.85 M(+7.5%) | -$51.60 M(+11.4%) |
| Dec 2023 | -$46.30 M(+53.0%) | -$14.75 M(+51.5%) | -$46.30 M(+16.5%) |
| Sep 2023 | - | -$9.73 M(-13.6%) | -$39.76 M(+7.8%) |
| Jun 2023 | - | -$11.27 M(+6.7%) | -$36.87 M(+9.1%) |
| Mar 2023 | - | -$10.56 M(+28.8%) | -$33.79 M(+11.7%) |
| Dec 2022 | -$30.26 M(+2.8%) | -$8.20 M(+19.8%) | -$30.26 M(+1.4%) |
| Sep 2022 | - | -$6.84 M(-16.4%) | -$29.85 M(-5.4%) |
| Jun 2022 | - | -$8.19 M(+16.5%) | -$31.57 M(+7.9%) |
| Mar 2022 | - | -$7.03 M(-9.7%) | -$29.26 M(-0.6%) |
| Dec 2021 | -$29.44 M(+8.4%) | -$7.79 M(-9.1%) | -$29.44 M(+6.1%) |
| Sep 2021 | - | -$8.56 M(+45.6%) | -$27.74 M(+7.6%) |
| Jun 2021 | - | -$5.88 M(-18.4%) | -$25.77 M(-10.6%) |
| Mar 2021 | - | -$7.21 M(+18.6%) | -$28.82 M(+6.1%) |
| Dec 2020 | -$27.16 M(+31.2%) | -$6.08 M(-7.8%) | -$27.16 M(+3.0%) |
| Sep 2020 | - | -$6.59 M(-26.2%) | -$26.38 M(+6.0%) |
| Jun 2020 | - | -$8.94 M(+61.0%) | -$24.88 M(+16.3%) |
| Mar 2020 | - | -$5.55 M(+4.8%) | -$21.39 M(+3.3%) |
| Dec 2019 | -$20.71 M(-22.8%) | -$5.30 M(+4.0%) | -$20.71 M(+56.2%) |
| Sep 2019 | - | -$5.09 M(-6.6%) | -$13.26 M(-27.9%) |
| Jun 2019 | - | -$5.45 M(+12.0%) | -$18.40 M(-14.4%) |
| Mar 2019 | - | -$4.87 M(-326.5%) | -$21.51 M(-19.8%) |
| Dec 2018 | -$26.83 M(-18.7%) | $2.15 M(-121.0%) | -$26.83 M(-31.7%) |
| Sep 2018 | - | -$10.24 M(+19.6%) | -$39.28 M(+0.7%) |
| Jun 2018 | - | -$8.56 M(-16.0%) | -$39.00 M(+9.6%) |
| Mar 2018 | - | -$10.18 M(-1.2%) | -$35.59 M(+7.8%) |
| Dec 2017 | -$33.00 M(+33.9%) | -$10.31 M(+3.6%) | -$33.00 M(+13.4%) |
| Sep 2017 | - | -$9.95 M(+93.4%) | -$29.10 M(+2.9%) |
| Jun 2017 | - | -$5.15 M(-32.3%) | -$28.27 M(+0.9%) |
| Mar 2017 | - | -$7.60 M(+18.7%) | -$28.01 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$24.64 M(+35.5%) | -$6.40 M(-29.9%) | -$24.53 M(+11.5%) |
| Sep 2016 | - | -$9.13 M(+86.8%) | -$22.00 M(+25.3%) |
| Jun 2016 | - | -$4.89 M(+18.7%) | -$17.56 M(+4.5%) |
| Mar 2016 | - | -$4.12 M(+6.5%) | -$16.80 M(-7.6%) |
| Dec 2015 | -$18.18 M(-11.1%) | -$3.87 M(-17.5%) | -$18.18 M(+10.0%) |
| Sep 2015 | - | -$4.69 M(+13.4%) | -$16.53 M(-2.1%) |
| Jun 2015 | - | -$4.13 M(-24.8%) | -$16.88 M(+82.7%) |
| Mar 2015 | - | -$5.50 M(+148.3%) | -$9.24 M(-54.8%) |
| Dec 2014 | -$20.45 M(+166.0%) | -$2.21 M(-56.0%) | -$20.45 M(-5.5%) |
| Sep 2014 | - | -$5.03 M(-243.4%) | -$21.64 M(+15.1%) |
| Jun 2014 | - | $3.51 M(-121.0%) | -$18.80 M(-20.3%) |
| Mar 2014 | - | -$16.71 M(+390.9%) | -$23.59 M(+206.9%) |
| Dec 2013 | -$7.69 M(+156.5%) | -$3.40 M(+55.6%) | -$7.69 M(+60.9%) |
| Sep 2013 | - | -$2.19 M(+69.6%) | -$4.78 M(+33.4%) |
| Jun 2013 | - | -$1.29 M(+59.9%) | -$3.58 M(+23.3%) |
| Mar 2013 | - | -$806.60 K(+62.9%) | -$2.91 M(-3.1%) |
| Dec 2012 | -$3.00 M(-58.2%) | -$495.00 K(-50.0%) | -$3.00 M(+14.6%) |
| Sep 2012 | - | -$990.90 K(+61.6%) | -$2.62 M(-38.1%) |
| Jun 2012 | - | -$613.00 K(-31.8%) | -$4.22 M(-30.6%) |
| Mar 2012 | - | -$898.90 K(+692.7%) | -$6.09 M(-15.0%) |
| Dec 2011 | -$7.17 M(-11.5%) | -$113.40 K(-95.6%) | -$7.17 M(-22.2%) |
| Sep 2011 | - | -$2.60 M(+4.9%) | -$9.21 M(+15.1%) |
| Jun 2011 | - | -$2.48 M(+25.4%) | -$8.00 M(+19.5%) |
| Mar 2011 | - | -$1.98 M(-8.3%) | -$6.69 M(-17.3%) |
| Dec 2010 | -$8.09 M(+33.7%) | -$2.15 M(+54.7%) | -$8.09 M(-18.3%) |
| Sep 2010 | - | -$1.39 M(+18.7%) | -$9.91 M(+6.2%) |
| Jun 2010 | - | -$1.17 M(-65.2%) | -$9.33 M(+6.1%) |
| Mar 2010 | - | -$3.37 M(-15.0%) | -$8.79 M(+45.2%) |
| Dec 2009 | -$6.05 M | -$3.97 M(+387.7%) | -$6.05 M(+190.4%) |
| Sep 2009 | - | -$813.80 K(+28.6%) | -$2.08 M(+64.0%) |
| Jun 2009 | - | -$632.60 K(-0.9%) | -$1.27 M(+99.1%) |
| Mar 2009 | - | -$638.20 K | -$638.20 K |
FAQ
- What is CorMedix annual earnings before interest & taxes?
- What is the all time high annual EBIT for CorMedix?
- What is CorMedix annual EBIT year-on-year change?
- What is CorMedix quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CorMedix?
- What is CorMedix quarterly EBIT year-on-year change?
- What is CorMedix TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CorMedix?
- What is CorMedix TTM EBIT year-on-year change?
What is CorMedix annual earnings before interest & taxes?
The current annual EBIT of CRMD is -$46.30 M
What is the all time high annual EBIT for CorMedix?
CorMedix all-time high annual earnings before interest & taxes is -$3.00 M
What is CorMedix annual EBIT year-on-year change?
Over the past year, CRMD annual earnings before interest & taxes has changed by -$16.04 M (-53.02%)
What is CorMedix quarterly earnings before interest & taxes?
The current quarterly EBIT of CRMD is -$2.77 M
What is the all time high quarterly EBIT for CorMedix?
CorMedix all-time high quarterly earnings before interest & taxes is $3.51 M
What is CorMedix quarterly EBIT year-on-year change?
Over the past year, CRMD quarterly earnings before interest & taxes has changed by +$11.98 M (+81.24%)
What is CorMedix TTM earnings before interest & taxes?
The current TTM EBIT of CRMD is -$47.51 M
What is the all time high TTM EBIT for CorMedix?
CorMedix all-time high TTM earnings before interest & taxes is -$638.20 K
What is CorMedix TTM EBIT year-on-year change?
Over the past year, CRMD TTM earnings before interest & taxes has changed by -$1.21 M (-2.60%)